AU2003255790B2 - Salt of morphine-6-glucuronide - Google Patents

Salt of morphine-6-glucuronide Download PDF

Info

Publication number
AU2003255790B2
AU2003255790B2 AU2003255790A AU2003255790A AU2003255790B2 AU 2003255790 B2 AU2003255790 B2 AU 2003255790B2 AU 2003255790 A AU2003255790 A AU 2003255790A AU 2003255790 A AU2003255790 A AU 2003255790A AU 2003255790 B2 AU2003255790 B2 AU 2003255790B2
Authority
AU
Australia
Prior art keywords
hbr
salt
subject
salts
morphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003255790A
Other languages
English (en)
Other versions
AU2003255790A1 (en
Inventor
John Aitken Graham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paion UK Ltd
Original Assignee
Paion UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion UK Ltd filed Critical Paion UK Ltd
Publication of AU2003255790A1 publication Critical patent/AU2003255790A1/en
Assigned to PAION UK LIMITED reassignment PAION UK LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: CENES LIMITED
Application granted granted Critical
Publication of AU2003255790B2 publication Critical patent/AU2003255790B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003255790A 2002-08-14 2003-08-14 Salt of morphine-6-glucuronide Ceased AU2003255790B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0218811.8 2002-08-14
GBGB0218811.8A GB0218811D0 (en) 2002-08-14 2002-08-14 Salts of morphine-6-glucuronide
PCT/GB2003/003562 WO2004016633A1 (en) 2002-08-14 2003-08-14 Salt of morphine-6-glucuronide

Publications (2)

Publication Number Publication Date
AU2003255790A1 AU2003255790A1 (en) 2004-03-03
AU2003255790B2 true AU2003255790B2 (en) 2010-05-27

Family

ID=9942230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255790A Ceased AU2003255790B2 (en) 2002-08-14 2003-08-14 Salt of morphine-6-glucuronide

Country Status (17)

Country Link
US (1) US20060166900A1 (enExample)
EP (1) EP1537132B1 (enExample)
JP (1) JP4727990B2 (enExample)
KR (1) KR101077501B1 (enExample)
AT (1) ATE315041T1 (enExample)
AU (1) AU2003255790B2 (enExample)
CA (1) CA2494812C (enExample)
DE (1) DE60303149T2 (enExample)
DK (1) DK1537132T3 (enExample)
EA (1) EA008212B1 (enExample)
ES (1) ES2256790T3 (enExample)
GB (1) GB0218811D0 (enExample)
IL (1) IL166596A0 (enExample)
NO (1) NO20051261L (enExample)
PL (1) PL211031B1 (enExample)
WO (1) WO2004016633A1 (enExample)
ZA (1) ZA200501053B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
CN107028968B (zh) * 2016-02-03 2020-12-04 江苏恒瑞医药股份有限公司 一种含有葡萄糖醛酸吗啡或其可药用盐的药物组合物
EP3528797A1 (en) 2016-10-21 2019-08-28 Somniferum Labs LLC Compositions, methods and kits for the safe inhaled delivery of targeted opioids for the treatment of pain and addiction
CN110054656B (zh) * 2019-05-28 2021-02-02 宜昌人福药业有限责任公司 一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
CN113831373B (zh) * 2020-06-23 2023-05-16 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖苷酸脱水物杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
FR2680786B1 (fr) * 1991-09-04 1995-03-10 Irepa Procede de synthese de glucuronides d'epoxy-4,5 morphinanes.
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
EP0816375A1 (en) * 1995-11-29 1998-01-07 Rolabo Sl Glycoconjugates of opiated substances
PT1017696E (pt) * 1997-09-25 2002-09-30 Lohmann Therapie Syst Lts Sais de adicao de acido de alcaloides de morfina e sua utilizacao
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain

Also Published As

Publication number Publication date
WO2004016633A1 (en) 2004-02-26
KR101077501B1 (ko) 2011-10-28
KR20050055710A (ko) 2005-06-13
US20060166900A1 (en) 2006-07-27
JP4727990B2 (ja) 2011-07-20
DE60303149D1 (de) 2006-03-30
CA2494812A1 (en) 2004-02-26
AU2003255790A1 (en) 2004-03-03
PL211031B1 (pl) 2012-04-30
GB0218811D0 (en) 2002-09-18
EA008212B1 (ru) 2007-04-27
ZA200501053B (en) 2005-10-26
CA2494812C (en) 2011-03-08
ES2256790T3 (es) 2006-07-16
JP2006500360A (ja) 2006-01-05
DK1537132T3 (da) 2006-05-08
EP1537132A1 (en) 2005-06-08
ATE315041T1 (de) 2006-02-15
PL373553A1 (en) 2005-09-05
IL166596A0 (en) 2006-01-15
NO20051261L (no) 2005-03-11
EA200500175A1 (ru) 2005-08-25
EP1537132B1 (en) 2006-01-04
DE60303149T2 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
IL307571A (en) A multi-mode convertible vehicle
IL307580A (en) Computer vision-based surgical workflow recognition system using natural language processing techniques
US4925870A (en) Therapeutic use of proanthocyanidine A2 as a cytoprotective agent
US4757057A (en) Oligo-heteropolysaccharides having a heparin-like activity method for their preparation and pharmaceutical compositions based thereon
EP0513543B1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
US4413004A (en) Pharmaceutical compositions
CA1142092A (en) Method of preventing carcinogenesis
JPH0524135B2 (enExample)
CA2160423A1 (en) Salts of nefazodone having improved dissolution rates
CN102300870A (zh) 低分子量多硫酸化透明质酸衍生物和含有它的医药
JPH03210302A (ja) 過硫酸化ヘパリン
CN103327993A (zh) 用于预防和治疗胃食管返流病的含金银花提取物的药物组合物
US5707973A (en) Sulfated polysaccharids for treatment or prevention of thromboses
IL307579A (en) Device and method for mixing fluids and for producing a fluid mixture
EP1537132B1 (en) Salt of morphine-6-glucuronide
PT89145B (pt) Processo para a preparacao de derivados da manumicina e de composicoes farmaceuticas que os contem
Grosman Inhibitory effect of phloretin on histamine release from isolated rat mast cells
KR101791226B1 (ko) 갈란진 또는 캠퍼롤을 포함하는 항노화 조성물
JP2000072665A (ja) ヒアルロニダーゼ阻害剤
DD297165A5 (de) Neue sulfatierte polysaccharide, physiologisch vertraegliche salze davon und verfahren zu ihrer herstellung
US4333926A (en) Steryl-β-D-glucoside pharmaceutical compositions and use
CN115590848B (zh) 补骨脂有效成分治疗雄激素依赖性疾病的用途
IE921287A1 (en) Sulphated polysaccharides, their preparation, pharmaceutical¹compositions containing them and their use
US5212201A (en) Xanthine oxidase inhibitor
KR102576397B1 (ko) 콜라게나제 저해 활성 펩타이드 유도체 및 이의 용도

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired